Vanguard Group
AUPH icon

Vanguard Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$14.6M Sell
1,720,878
-250,928
-13% -$2.13M ﹤0.01% 2712
2025
Q1
$15.9M Buy
1,971,806
+241,858
+14% +$1.94M ﹤0.01% 2612
2024
Q4
$15.5M Buy
1,729,948
+112,113
+7% +$1.01M ﹤0.01% 2714
2024
Q3
$11.9M Buy
1,617,835
+78,723
+5% +$577K ﹤0.01% 2869
2024
Q2
$8.79M Buy
1,539,112
+7,495
+0.5% +$42.8K ﹤0.01% 2997
2024
Q1
$7.67M Buy
1,531,617
+21,119
+1% +$106K ﹤0.01% 3106
2023
Q4
$13.6M Buy
1,510,498
+26,230
+2% +$236K ﹤0.01% 2786
2023
Q3
$11.5M Buy
1,484,268
+101,751
+7% +$791K ﹤0.01% 2806
2023
Q2
$13.4M Buy
1,382,517
+54,407
+4% +$527K ﹤0.01% 2787
2023
Q1
$14.6M Sell
1,328,110
-46,413
-3% -$509K ﹤0.01% 2748
2022
Q4
$5.94M Buy
1,374,523
+166,914
+14% +$721K ﹤0.01% 3220
2022
Q3
$9.08M Buy
1,207,609
+38,652
+3% +$291K ﹤0.01% 2991
2022
Q2
$11.7M Buy
1,168,957
+638,898
+121% +$6.42M ﹤0.01% 2907
2022
Q1
$6.56M Buy
530,059
+110,354
+26% +$1.37M ﹤0.01% 3381
2021
Q4
$9.6M Buy
419,705
+347,094
+478% +$7.94M ﹤0.01% 3231
2021
Q3
$1.61M Buy
72,611
+75
+0.1% +$1.66K ﹤0.01% 4126
2021
Q2
$940K Sell
72,536
-19,890
-22% -$258K ﹤0.01% 4165
2021
Q1
$1.2M Sell
92,426
-2,728
-3% -$35.4K ﹤0.01% 3975
2020
Q4
$1.32M Buy
95,154
+15,226
+19% +$211K ﹤0.01% 3763
2020
Q3
$1.18M Buy
79,928
+22,626
+39% +$333K ﹤0.01% 3621
2020
Q2
$931K Sell
57,302
-39,844
-41% -$647K ﹤0.01% 3631
2020
Q1
$1.41M Buy
97,146
+49,197
+103% +$714K ﹤0.01% 3398
2019
Q4
$971K Buy
47,949
+18,929
+65% +$383K ﹤0.01% 3649
2019
Q3
$155K Hold
29,020
﹤0.01% 3988
2019
Q2
$191K Buy
29,020
+4,549
+19% +$29.9K ﹤0.01% 3984
2019
Q1
$159K Buy
24,471
+9,700
+66% +$63K ﹤0.01% 3955
2018
Q4
$101K Hold
14,771
﹤0.01% 3998
2018
Q3
$98K Hold
14,771
﹤0.01% 4076
2018
Q2
$83K Hold
14,771
﹤0.01% 4068
2018
Q1
$77K Hold
14,771
﹤0.01% 4051
2017
Q4
$67K Buy
+14,771
New +$67K ﹤0.01% 4022